As one of the widespread malignancy, lung adenocarcinoma (LUAD) is characterised by low 5-year survival price. This analysis aimed to analyze the results of ribonucleotide reductase regulatory subunit M2 (RRM2) on malignant organic behaviors and activation of cGAS/STING pathway. We additionally explored the synergistic sensitization mechanisms of RRM2 and radiotherapy. Bioinformatic instruments have been used… Continue reading
